THC Biomed Intl Ltd
THC Biomed Intl Ltd. engages in the research, development, production, and sale of cannabis products in Canada. The company offers cannabis consumables, including beverage drinks, gummies, baked goods, pre-rolls, sticks, and clones under the THC Kiss brand name; and genetic strains under the THC BioMed brand name. It also provides dry flowers under the Smoke That Thunders brand name; buds under t… Read more
THC Biomed Intl Ltd (THCBF) - Net Assets
Latest net assets as of April 2023: $4.70 Million USD
Based on the latest financial reports, THC Biomed Intl Ltd (THCBF) has net assets worth $4.70 Million USD as of April 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.72 Million) and total liabilities ($9.02 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.70 Million |
| % of Total Assets | 34.25% |
| Annual Growth Rate | N/A |
| 5-Year Change | -43.24% |
| 10-Year Change | N/A |
| Growth Volatility | 536.48 |
THC Biomed Intl Ltd - Net Assets Trend (2001–2022)
This chart illustrates how THC Biomed Intl Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for THC Biomed Intl Ltd (2001–2022)
The table below shows the annual net assets of THC Biomed Intl Ltd from 2001 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-07-31 | $6.93 Million | -29.13% |
| 2021-07-31 | $9.78 Million | -34.22% |
| 2020-07-31 | $14.87 Million | +10.54% |
| 2019-07-31 | $13.45 Million | +10.15% |
| 2018-07-31 | $12.21 Million | +517.11% |
| 2017-07-31 | $1.98 Million | +464.44% |
| 2016-07-31 | $350.67K | +123.15% |
| 2015-07-31 | $-1.51 Million | -1298.05% |
| 2014-07-31 | $-108.34K | +77.82% |
| 2013-07-31 | $-488.39K | -20.36% |
| 2012-07-31 | $-405.78K | -105.30% |
| 2011-07-31 | $7.66 Million | +2104.71% |
| 2010-07-31 | $347.33K | -90.12% |
| 2009-07-31 | $3.51 Million | -10.36% |
| 2008-07-31 | $3.92 Million | -2.25% |
| 2007-07-31 | $4.01 Million | +34.89% |
| 2006-07-31 | $2.97 Million | -2.19% |
| 2005-07-31 | $3.04 Million | -0.75% |
| 2004-07-31 | $3.06 Million | +124.41% |
| 2003-07-31 | $1.36 Million | +716.46% |
| 2002-07-31 | $167.15K | +389.83% |
| 2001-07-31 | $-57.67K | -- |
Equity Component Analysis
This analysis shows how different components contribute to THC Biomed Intl Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2160078400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $31.66 Million | 456.71% |
| Other Comprehensive Income | $606.96K | 8.75% |
| Total Equity | $6.93 Million | 100.00% |
THC Biomed Intl Ltd Competitors by Market Cap
The table below lists competitors of THC Biomed Intl Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
O.R.T.
TA:ORTC
|
$116.42K |
|
SurgePays Inc. Warrant
NASDAQ:SURGW
|
$116.47K |
|
Hanna Capital Corp
F:04U1
|
$116.52K |
|
Saxon Capital Group Inc
PINK:SCGX
|
$116.58K |
|
Blackrock Multi Sector Income Closed Fund
NYSE:BIT
|
$116.31K |
|
Brightstar Lottery PLC
NYSE:BRSL
|
$116.29K |
|
Southern BancShares (N.C.) Inc. PFD CV B
PINK:SBNCM
|
$116.24K |
|
Daesang Corp. Pfd. Series 1
KQ:001685
|
$116.19K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in THC Biomed Intl Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 9,783,409 to 6,933,131, a change of -2,850,278 (-29.1%).
- Net loss of 3,065,848 reduced equity.
- New share issuances of 15,000 increased equity.
- Other comprehensive income decreased equity by 8,086,216.
- Other factors increased equity by 8,286,786.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.07 Million | -44.22% |
| Share Issuances | $15.00K | +0.22% |
| Other Comprehensive Income | $-8.09 Million | -116.63% |
| Other Changes | $8.29 Million | +119.52% |
| Total Change | $- | -29.13% |
Book Value vs Market Value Analysis
This analysis compares THC Biomed Intl Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-07-31 | $-0.42 | $0.00 | x |
| 2002-07-31 | $1.03 | $0.00 | x |
| 2003-07-31 | $1.20 | $0.00 | x |
| 2004-07-31 | $1.64 | $0.00 | x |
| 2005-07-31 | $1.27 | $0.00 | x |
| 2006-07-31 | $0.78 | $0.00 | x |
| 2007-07-31 | $0.87 | $0.00 | x |
| 2008-07-31 | $0.68 | $0.00 | x |
| 2009-07-31 | $0.54 | $0.00 | x |
| 2010-07-31 | $0.04 | $0.00 | x |
| 2011-07-31 | $0.24 | $0.00 | x |
| 2012-07-31 | $-0.01 | $0.00 | x |
| 2013-07-31 | $-0.07 | $0.00 | x |
| 2014-07-31 | $-0.01 | $0.00 | x |
| 2015-07-31 | $-0.04 | $0.00 | x |
| 2016-07-31 | $0.00 | $0.00 | x |
| 2017-07-31 | $0.02 | $0.00 | x |
| 2018-07-31 | $0.11 | $0.00 | x |
| 2019-07-31 | $0.10 | $0.00 | x |
| 2020-07-31 | $0.10 | $0.00 | x |
| 2021-07-31 | $0.06 | $0.00 | x |
| 2022-07-31 | $0.04 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently THC Biomed Intl Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -44.22%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -125.15%
- • Asset Turnover: 0.17x
- • Equity Multiplier: 2.13x
- Recent ROE (-44.22%) is above the historical average (-83.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 0.00% | 0.00% | 0.00x | 0.00x | $-229.53K |
| 2002 | -70.94% | 0.00% | 0.00x | 1.30x | $-135.29K |
| 2003 | -17.49% | 0.00% | 0.00x | 1.04x | $-375.13K |
| 2004 | -22.37% | 0.00% | 0.00x | 1.02x | $-991.22K |
| 2005 | -39.31% | 0.00% | 0.00x | 1.02x | $-1.50 Million |
| 2006 | -79.55% | 0.00% | 0.00x | 1.01x | $-2.66 Million |
| 2007 | -32.96% | 0.00% | 0.00x | 1.02x | $-1.72 Million |
| 2008 | -22.61% | 0.00% | 0.00x | 1.01x | $-1.28 Million |
| 2009 | -15.31% | 0.00% | 0.00x | 1.03x | $-889.56K |
| 2010 | -1095.46% | 0.00% | 0.00x | 1.49x | $-3.84 Million |
| 2011 | -31.10% | 0.00% | 0.00x | 1.05x | $-3.15 Million |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-8.07 Million |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-322.22K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-204.51K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.91 Million |
| 2016 | -81.66% | -57.27% | 0.31x | 4.57x | $-321.41K |
| 2017 | -30.56% | -1010.20% | 0.01x | 3.52x | $-802.80K |
| 2018 | -102.00% | -1346.42% | 0.06x | 1.19x | $-13.68 Million |
| 2019 | -94.39% | -852.53% | 0.08x | 1.34x | $-14.04 Million |
| 2020 | -1.09% | -3.87% | 0.19x | 1.46x | $-1.65 Million |
| 2021 | -65.00% | -168.49% | 0.22x | 1.78x | $-7.34 Million |
| 2022 | -44.22% | -125.15% | 0.17x | 2.13x | $-3.76 Million |
Industry Comparison
This section compares THC Biomed Intl Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| THC Biomed Intl Ltd (THCBF) | $4.70 Million | 0.00% | 1.92x | $116.34K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |